Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan’s First Quarter Rubella Cases Double Last Year’s Figures

This article was originally published in PharmAsia News

Executive Summary

The number of cases of rubella, which can have effects on babies if pregnant women are infected, have reached twice the figures of last year in the first quarter of 2013 in Japan.

The number of cases of rubella, which can have effects on babies if pregnant women are infected, have reached twice the figures of last year in the first quarter of 2013 in Japan. According to an expert, the risk of infection could increase further as people are moving around during the Golden Week holiday period. Rubella, which appears as a rash and fever and can spread through coughing and sneezing, can cause faults in a baby’s eyes, ears, and heart if the pregnant mother is infected. The National Institute of Diseases hopes vaccines can be administered quickly as the peak of period of infections is still to come in June.(Click Here For More – Japanese Language)

“Rubella Patients Double The Number From Last Year” - nhk.or.jp 04/30/201

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC084246

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel